Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, N-phenethyl-4-piperdone (NPP)

HS v2022 Code: 293337

About heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, n-phenethyl-4-piperdone (npp)

HS code 293337 covers a class of heterocyclic organic compounds known as N-phenethyl-4-piperdone (NPP). These compounds play a crucial role in the pharmaceutical and chemical industries, serving as key intermediates in the production of various medications and other specialized products. As a versatile building block, NPP and related heterocyclic compounds find applications across a wide range of sectors, contributing to the broader economic landscape.

Production process

The production of NPP and related heterocyclic compounds typically involves a multi-step synthesis process. The key steps often include the cyclization of appropriate precursors, followed by various functionalization reactions to introduce the desired substituents. Depending on the specific target compound, the synthesis may employ a range of techniques, such as nucleophilic addition, electrophilic substitution, or transition metal-catalyzed transformations.

Production inputs

The main inputs required for the production of NPP and related heterocyclic compounds include a variety of organic precursors, such as pyridine derivatives, as well as specialized reagents and catalysts. Additionally, the process may require specialized laboratory equipment, including reactors, distillation columns, and purification systems, to ensure the efficient and high-quality production of these valuable intermediates.

Production outputs

The primary output of HS code 293337 is the N-phenethyl-4-piperdone (NPP) compound, which serves as a key intermediate in the synthesis of various pharmaceutical and chemical products. The heterocyclic compounds produced under this code may be further processed and incorporated into the manufacturing of 300000 Pharmaceutical products, 380000 Chemical products, and other related industries.

Revisions to 293337

Classification codes are adjusted frequently. The code may have been revised or replaced between system versions. The table below shows the history (newest to oldest) of the code 293337. The most recent 1 version of this code (293337) is in the HS v2022 system (this version):

This page shows the most recent version of code 293337.

Older versions

HS v2017:
- 293339: Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, n.e.c. in 2933.3

Family tree for heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, n-phenethyl-4-piperdone (npp)

    graph LR
    A["<a href='/classifications/hs/v2022/29'>29: Organic chemicals</a>"]
A --> B["<a href='/classifications/hs/v2022/2933'>2933: Heterocyclic compounds with nitrogen hetero-atom(s) only</a>"]
B --> C["<a href='/classifications/hs/v2022/293337'>293337: Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, N-phenethyl-4-piperdone (NPP)</a>"]

    B --> D["<a href='/classifications/hs/v2022/293311'>293311: Heterocyclic compounds; with nitrogen hetero-atom(s) only, containing an unfused pyrazole ring (whether or not hydrogenated) in the structure, phenazone (antipyrin) and its derivatives</a>"]
B --> E["<a href='/classifications/hs/v2022/293319'>293319: Heterocyclic compounds; with nitrogen hetero-atom(s) only, containing an unfused pyrazole ring (whether or not hydrogenated) in the structure, other than henazone (antipyrin) and its derivatives</a>"]
B --> F["<a href='/classifications/hs/v2022/293321'>293321: Heterocyclic compounds; with nitrogen hetero-atom(s) only, containing an unfused imidazole ring (whether or not hydrogenated) in the structure, hydantoin and its derivatives</a>"]
B --> G["<a href='/classifications/hs/v2022/293329'>293329: Heterocyclic compounds; with nitrogen hetero-atom(s) only, containing an unfused imidazole ring (whether or not hydrogenated) in the structure, other than hydantoin and its derivatives</a>"]
B --> H["<a href='/classifications/hs/v2022/293331'>293331: Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, pyridine and its salts</a>"]
B --> I["<a href='/classifications/hs/v2022/293332'>293332: Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, piperidine and its salts</a>"]
B --> J["<a href='/classifications/hs/v2022/293333'>293333: Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, alfentanil (INN), anileridine (INN), bezitramide (INN), bromazepam (INN), carfentanil (INN), difenoxin (INN), diphenoxylate (INN), dipipanone (INN)</a>"]
B --> K["<a href='/classifications/hs/v2022/293334'>293334: Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other fentanyls and their derivatives</a>"]
B --> L["<a href='/classifications/hs/v2022/293335'>293335: Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, 3-quinuclidinol</a>"]
B --> M["<a href='/classifications/hs/v2022/293336'>293336: Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, 4-anilino-N-phenethylpiperidine (ANPP)</a>"]
B --> N["<a href='/classifications/hs/v2022/293339'>293339: Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, n.e.c. in 2933.3</a>"]
B --> O["<a href='/classifications/hs/v2022/293341'>293341: Heterocyclic compounds; containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused, levorphanol (INN) and its salts</a>"]
B --> P["<a href='/classifications/hs/v2022/293349'>293349: Heterocyclic compounds; containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused, other than levorphanol (INN) and its salts</a>"]
B --> Q["<a href='/classifications/hs/v2022/293352'>293352: Heterocyclic compounds; containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, malonylurea (barbituric acid) and its salts</a>"]
B --> R["<a href='/classifications/hs/v2022/293353'>293353: Allobarbital (INN), amobarbital (INN), barbital (INN), butalbital (INN), butobarbital, cyclobarbital (INN), methylphenobarbital (INN), pentobarbital (INN), phenobarbital (INN), secbutabarbital (INN), secobarbital (INN) and vinylbital (INN); salts thereof</a>"]
B --> S["<a href='/classifications/hs/v2022/293354'>293354: Heterocyclic compounds; containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, other derivatives of malonylurea (barbituric acid) and salts thereof, n.e.c. in 2933.53</a>"]
B --> T["<a href='/classifications/hs/v2022/293355'>293355: Heterocyclic compounds; containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure; loprazolam (INN), mecloqualone (INN), methaqualone (INN), and zipeprol (INN); salts thereof</a>"]
B --> U["<a href='/classifications/hs/v2022/293359'>293359: Heterocyclic compounds; containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5</a>"]
B --> V["<a href='/classifications/hs/v2022/293361'>293361: Heterocyclic compounds; containing an unfused triazine ring (whether or not hydrogenated) in the structure, melamine</a>"]
B --> W["<a href='/classifications/hs/v2022/293369'>293369: Heterocyclic compounds; containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamine</a>"]
B --> X["<a href='/classifications/hs/v2022/293371'>293371: Heterocyclic compounds; lactams; 6-hexanelactam (epsilon-caprolactam)</a>"]
B --> Y["<a href='/classifications/hs/v2022/293372'>293372: Heterocyclic compounds; lactams; clobazam (INN) and methyprylon (INN)</a>"]
B --> Z["<a href='/classifications/hs/v2022/293379'>293379: Heterocyclic compounds; lactams; other than 6-hexanelactam (epsilon caprolactam) and clobazam (INN) and methyprylon (INN)</a>"]
B --> BA["<a href='/classifications/hs/v2022/293391'>293391: Heterocyclic compounds; alprazolam (INN), camazepam (INN), chlordiazepoxide (INN), clonazepam (INN), clorazepate, delorazepam (INN), diazepam (INN), estazolam (INN), ethyl loflazepate (INN), fludiazepam (INN), flunitrazepam (INN), (cont)</a>"]
B --> BB["<a href='/classifications/hs/v2022/293392'>293392: Heterocyclic compounds; azinphos-methyl (ISO)</a>"]
B --> BC["<a href='/classifications/hs/v2022/293399'>293399: Heterocyclic compounds; n.e.c. in headings no. 2933</a>"]

    

    %% Color coordination by level

    classDef level1 color:#000,fill:#a8f9ff,stroke:#333,stroke-width:2px
    classDef level2 color:#000,fill:#e0a458,stroke:#333,stroke-width:1px
    classDef level3 color:#000,fill:#419d78,stroke:#333,stroke-width:1px
    classDef level4 color:#000,fill:#c04abc,stroke:#333,stroke-width:1px
    classDef level5 color:#000,fill:#f1c40f,stroke:#333,stroke-width:1px
    classDef level6 color:#000,fill:#f1c40f,stroke:#333,stroke-width:1px
    classDef highlight color:#000,fill:#fff,stroke:#000,stroke-width:5px



  %% Apply classes
  class A level2
class B level4
class C level6
class D level6
class E level6
class F level6
class G level6
class H level6
class I level6
class J level6
class K level6
class L level6
class M level6
class N level6
class O level6
class P level6
class Q level6
class R level6
class S level6
class T level6
class U level6
class V level6
class W level6
class X level6
class Y level6
class Z level6
class BA level6
class BB level6
class BC level6

  class C highlight

  %% class A level1
  %% class B,C level2
  %% class D,E,F,G,H,I level2
  %% class J,K,L,M,N,O,P level3
  %% class C highlight

Code	293337
Version	HS v2022
Hierarchy Level	6
Datasource	WCO
Chapter	29
Heading	2933